- CONTACT US
- About G&E
- Practice Areas
- U.S. Securities Litigation
- International Securities Litigation
- Corporate Governance Litigation
- M&A Litigation
- Alternative Investment Litigation
- Antitrust Litigation
- International Arbitration
- Bankruptcy & Distressed Litigation
- Public Entity Litigation
- Environmental/Toxic Tort Litigation
- Complex & Mass Tort Litigation
- Birth Injury Litigation
- Child Victims Act and Clergy Litigation
- Civil Rights, Sexual Assault/Harassment & Discrimination Litigation
- Consumer Litigation
- Whistleblower/False Claims Litigation
- Cases
- Attorneys
- Client Services
- News & Events
Representative Cases
GlaxoSmithKline
G&E represented one of several whistleblowers in a case against pharmaceutical giant GlaxoSmithKline (GSK) that resulted in a $1.04 billion recovery for the federal and state governments. The suit arose from alleged misrepresentation by GSK in its promotion of the company’s popular asthma and Chronic Obstructive Pulmonary Disease (COPD) medication, Advair.
Company
GlaxoSmithKline
Case Name
U.S. ex rel. Graydon v. GlaxoSmithKline
Settlement
$1.04 Billion
Court
District of Massachusetts
Copyright © Grant & Eisenhofer P.A. All Rights Reserved.